CRBP
Price
$7.71
Change
-$0.04 (-0.52%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
94.35M
FBIO
Price
$1.88
Change
+$0.05 (+2.73%)
Updated
Jul 3 closing price
Capitalization
55.59M
Interact to see
Advertisement

CRBP vs FBIO

Header iconCRBP vs FBIO Comparison
Open Charts CRBP vs FBIOBanner chart's image
Corbus Pharmaceuticals Holdings
Price$7.71
Change-$0.04 (-0.52%)
Volume$4.99K
Capitalization94.35M
Fortress Biotech
Price$1.88
Change+$0.05 (+2.73%)
Volume$180.98K
Capitalization55.59M
CRBP vs FBIO Comparison Chart in %
Loading...
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBP vs. FBIO commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBP is a StrongBuy and FBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (CRBP: $7.71 vs. FBIO: $1.88)
Brand notoriety: CRBP and FBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBP: 49% vs. FBIO: 96%
Market capitalization -- CRBP: $94.35M vs. FBIO: $55.59M
CRBP [@Biotechnology] is valued at $94.35M. FBIO’s [@Biotechnology] market capitalization is $55.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBP’s FA Score shows that 0 FA rating(s) are green whileFBIO’s FA Score has 1 green FA rating(s).

  • CRBP’s FA Score: 0 green, 5 red.
  • FBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, both CRBP and FBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBP’s TA Score shows that 5 TA indicator(s) are bullish while FBIO’s TA Score has 4 bullish TA indicator(s).

  • CRBP’s TA Score: 5 bullish, 4 bearish.
  • FBIO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRBP is a better buy in the short-term than FBIO.

Price Growth

CRBP (@Biotechnology) experienced а -3.87% price change this week, while FBIO (@Biotechnology) price change was +1.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CRBP is expected to report earnings on May 06, 2025.

FBIO is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBP($94.3M) has a higher market cap than FBIO($55.6M). FBIO YTD gains are higher at: -7.160 vs. CRBP (-34.661). CRBP has higher annual earnings (EBITDA): -48.74M vs. FBIO (-89.64M). CRBP has more cash in the bank: 133M vs. FBIO (91.3M). CRBP has less debt than FBIO: CRBP (2.86M) vs FBIO (74.2M). FBIO has higher revenues than CRBP: FBIO (57.8M) vs CRBP (0).
CRBPFBIOCRBP / FBIO
Capitalization94.3M55.6M170%
EBITDA-48.74M-89.64M54%
Gain YTD-34.661-7.160484%
P/E RatioN/AN/A-
Revenue057.8M-
Total Cash133M91.3M146%
Total Debt2.86M74.2M4%
FUNDAMENTALS RATINGS
CRBP vs FBIO: Fundamental Ratings
CRBP
FBIO
OUTLOOK RATING
1..100
5670
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
32
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6354
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIO's Valuation (32) in the Biotechnology industry is in the same range as CRBP (50). This means that FBIO’s stock grew similarly to CRBP’s over the last 12 months.

FBIO's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CRBP (100). This means that FBIO’s stock grew similarly to CRBP’s over the last 12 months.

CRBP's SMR Rating (96) in the Biotechnology industry is in the same range as FBIO (100). This means that CRBP’s stock grew similarly to FBIO’s over the last 12 months.

FBIO's Price Growth Rating (54) in the Biotechnology industry is in the same range as CRBP (63). This means that FBIO’s stock grew similarly to CRBP’s over the last 12 months.

FBIO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CRBP (100). This means that FBIO’s stock grew similarly to CRBP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRBPFBIO
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CRBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NEGXF0.20N/A
N/A
Nexgenrx, Inc.
MDDNF3.43N/A
N/A
Meridian Energy LTD
NTCYF42.85N/A
N/A
Netcompany Group AS
CNTHO42.70-0.25
-0.58%
Connecticut Light & Power Co. (The)
MFGCF1.23-0.01
-0.81%
Mayfair Gold Corp.

CRBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBP has been loosely correlated with SKYE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBP jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBP
1D Price
Change %
CRBP100%
-0.52%
SKYE - CRBP
46%
Loosely correlated
+23.26%
FBIO - CRBP
38%
Loosely correlated
+2.73%
STOK - CRBP
37%
Loosely correlated
-0.61%
APLS - CRBP
35%
Loosely correlated
+2.47%
CCCC - CRBP
30%
Poorly correlated
-2.63%
More